EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Why does local edema persist? Immunological mismatch between phospholipase A2 potency and antivenom affinity in Protobothrops mucrosquamatus envenomation

Cheng-Hsuan Ho iD, Yu-Wei Chiang, Yan-Chiao Mao, Chih-Hsiung Hsu, Feng-Chen Chen, Shih-Hung Tsai, Shing-Hwa Liu

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Cheng-Hsuan Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Antivenins, Edema, Snake Bites, Phospholipases A2. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Protobothrops mucrosquamatus is the primary species responsible for snakebite morbidity in Taiwan, typically resulting in severe localized tissue edema. Although freeze-dried hemorrhagic antivenom (FHAV) is the standard treatment, persistent swelling remains a frequent clinical challenge. This study aimed to identify primary edematogenic toxins and evaluate the neutralizing efficacy of FHAV and small-molecule inhibitors (SMIs) to address this therapeutic gap. Methodology/principal findings Multiple linear regression of a retrospective cohort of 50 patients was used to identify predictors of edema remission. Experimentally, a murine paw edema model was established to evaluate the potency of crude venom and isolated fractions (PLA 2 , SVSP, and SVMP/CTL), whereas ELISA was used to determine FHAV immunoreactivity. Clinically, total FHAV dosage was the strongest independent predictor of the remission timeline ( β = 0.658, T = 5.167, P < 0.001), accounting for 69.8% of the variance. Experimentally, the PLA 2 -enriched fraction was identified as the primary edematogenic driver, eliciting swelling at 100 μg/mL, which was statistically indistinguishable from that of crude venom, whereas the other fractions required fivefold higher concentrations to achieve similar effects. However, ELISA revealed a significant immunological mismatch: the SVMP/CTL fraction sequestered 81.49% of the FHAV, indicating that highly potent PLA 2 was poorly targeted. Furthermore, SMIs (varespladib, marimastat, and batimastat) at 10 μM exhibited limited efficacy against crude venom-induced edema, suggesting that single-target interventions against the complex venom proteome are insufficient. Conclusions/significance Persistent localized edema arises from an immunological mismatch in which FHAV recognizes primarily high-molecular-weight immunogens instead of the primary edematogenic driver, PLA 2 . Current clinical management necessitates increasing FHAV dosages to compensate for low specific affinity through increased total antibody volume. These findings highlight that robust prospective multicenter trials are urgently needed to transition from empirical dosing to standardized, potency-aligned FHAV protocols, potentially incorporating multimodal therapeutic cocktails to achieve comprehensive neutralization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiveninsEdemaSnake BitesPhospholipases A2Crotalid VenomsAnimalsHumansMiceMaleFemaleRetrospective StudiesDisease Models, AnimalTaiwanEnzyme-Linked Immunosorbent AssayCrotalinaeVenomous Snakes

Substanzen

AntiveninsPhospholipases A2Crotalid Venoms

Autor:innen und Institutionen

  • Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Institute of Preventive Medicine, National Defense Medical University, New Taipei, Taiwan.
  • Department of Biology and Anatomy, National Defense Medical University, Taipei, Taiwan.
  • Department of Medical Toxicology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • School of Public Health, National Defense Medical University, Taipei, Taiwan.

ORCID-Profile: Cheng-Hsuan Ho

Förderung

  • Tri-Service General Hospital

Zitieren

APA

Ho, C. H., Chiang, Y. W., Mao, Y. C., Hsu, C. H., Chen, F. C., Tsai, S. H., & Liu, S. H. (2026). Why does local edema persist? Immunological mismatch between phospholipase A2 potency and antivenom affinity in Protobothrops mucrosquamatus envenomation. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014689

Vancouver

Ho CH, Chiang YW, Mao YC, Hsu CH, Chen FC, Tsai SH, et al. Why does local edema persist? Immunological mismatch between phospholipase A2 potency and antivenom affinity in Protobothrops mucrosquamatus envenomation. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014689

BibTeX
@article{Ho2026,
  author = {Ho, Cheng-Hsuan and Chiang, Yu-Wei and Mao, Yan-Chiao and Hsu, Chih-Hsiung and Chen, Feng-Chen and Tsai, Shih-Hung and Liu, Shing-Hwa},
  title = {Why does local edema persist? Immunological mismatch between phospholipase A2 potency and antivenom affinity in Protobothrops mucrosquamatus envenomation},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014689}
}
Kostenlos starten →